Carcinoma of the Male Breast: A Review of 41 Cases

Digenis, Alexander; Ross, C. F.; Morrison, John C.; Holcomb, George; Reynolds, V. Baksa

doi:10.1097/00007611-199010000-00011

Cited by 36 publications

(22 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…50 Yet another histotype reported in males-secretory carcinoma-is typically confined to children, adolescents, and very young adults. 50 • 77 Contesso et al 82 Borgen et al 27 Digenis et al 12 Cutuli et al 8 3 Schuchardt et al 8 4 Williams et al 85 Bezwoda et al 57 Friedman et al 76 Prechtel and Prechtel 16 Tan and Sng 8 6 McLachlan et al 87 Munoz de Toro and Luque 88 Rogers et al 8 9 Willsher et al 2 6 Gough et al 1 4 Total * Stages I-IV were included in all studies. Not specified indicates that the factor was studied, but details were not specified in the publication.…”

Section: Discussionmentioning

confidence: 99%

Low-Stage Carcinoma of the Male Breast: A Histologic, Immunohistochemical, and Flow Cytometric Comparison with Localized Female Breast Carcinoma

et al. 1999

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Low-Stage Carcinoma of the Male Breast: A Histologic, Immunohistochemical, and Flow Cytometric Comparison with Localized Female Breast Carcinoma

et al. 1999

View full text Add to dashboard Cite

show abstract

“…A few retrospective studies in male breast cancer demonstrated that lymph node status is an independent prognostic factor in survival [8,[34][35][36][37].…”

Section: Nodal Statusmentioning

confidence: 99%

“…The traditional approach in male breast cancer is modified radical mastectomy. Although randomized studies have not been carried out in male breast cancer, the few retrospective studies suggest the same results with modified radical mastectomy as with radical mastectomy in terms of recurrence and survival [34][35][36]46]. Lumpectomy is not generally considered because of there being less breast tissue and a more central location of this cancer [46,47].…”

Section: Surgerymentioning

confidence: 99%

Management of male breast cancer

2008

View full text Add to dashboard Cite

The management of male breast cancer is still under discussion due to lack of information from prospective, randomized clinical trials and low incidence of this disease. Current management is based largely on extrapolation from data related to treatment of female breast cancer. Over the last two decades, several review articles have discussed mainly retrospective and anecdotal data related to hormonal and chemotherapy treatment modalities. In this review, we present the most recent information and future considerations related to the management of male breast cancer. In addition to the conventional treatment options we will discuss the possible role of targeted therapy. Establishing a national or global registry for male breast cancer will provide more precise information about the natural history of the disease and will facilitate the design and execution of prospective, randomized multicenter clinical trials.

show abstract

“…37,127 Reported distant relapse rates are 18% to 40%, whereas locoregional relapse rates are 5% to 19%. [37][38][39][40] The mean time from initial diagnosis to distant relapse is about 26 months, 74,132 and the average time from the diagnosis of metastasis to death is 8 to 26 months. 74 …”

Section: What Is the Prognosis For Male Breast Cancer?mentioning

confidence: 99%